{
  "casebody": {
    "data": "<casebody firstpage=\"866\" lastpage=\"867\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties data-order=\"0\" data-type=\"parties\" id=\"b890-8\">CLASSEN IMMUNOTHERAPIES, INC., Plaintiff-Appellant, v. BIOGEN IDEC, Defendant-Appellee, and GlaxoSmithKline, Defendant-Appellee, and Merck &amp; Co., Inc., Defendant-Cross Appellant, and Chiron Corporation, Kaiser-Permanente, Inc., Kaiser Permanente Ventures, Kaiser Permanente International, Kaiser Permanente Insurance Company, The Permanente Federation, LLC, The Permanente Company, LLC, The Permanente Foundation, The Permanente Medical Group, Inc., Kaiser Foundation Hospitals, Kaiser Foundation Added Choice Health Plan, Inc., And Kaiser Foundation Health Plan Inc., Defendants.</parties>\n<docketnumber data-order=\"1\" data-type=\"docketnumber\" id=\"b890-15\">Nos. 2006-1634, 2006-1649.</docketnumber>\n<court data-order=\"2\" data-type=\"court\" id=\"b890-16\">United States Court of Appeals, Federal Circuit.</court>\n<decisiondate data-order=\"3\" data-type=\"decisiondate\" id=\"b890-17\">Dec. 19, 2008.</decisiondate>\n<otherdate data-order=\"4\" data-type=\"otherdate\" id=\"b890-18\">Rehearing and Rehearing En Banc Denied Feb. 9, 2009.<footnotemark>*</footnotemark></otherdate>\n<attorneys data-order=\"5\" data-type=\"attorneys\" id=\"b891-10\"><page-number citation-index=\"1\" label=\"867\">*867</page-number>Joseph J. Zito, Zito tip, of Washington, DC, argued for plaintiff-appellant.</attorneys>\n<attorneys data-order=\"6\" data-type=\"attorneys\" id=\"b891-11\">Joshua M. Hiller, Wilmer Cutler Pickering Hale and Dorr LLP, of Boston, MA, for defendant-appellee, Biogen IDEC. On the brief were David B. Bassett, of New York, NY, and David A. Wilson, of Washington, DC.</attorneys>\n<attorneys data-order=\"7\" data-type=\"attorneys\" id=\"b891-12\">George F. Pappas, Covington <em>&amp; </em>Burling LLP, of Washington, DC, argued for defendant-appellee, GlaxoSmithKline. With him on the brief were Jeffrey B. Elikan and Kevin B. Collins. Of counsel was Scott C. Weidenfeller.</attorneys>\n<attorneys data-order=\"8\" data-type=\"attorneys\" id=\"b891-13\">Mary B. Graham, Morris, Nichols, Arsht &amp; Tunnell, LLP, of Wilmington, DE, argued for defendant-cross appellant. With her on the brief was James W. Parrett, Jr. Of counsel on the brief were Robert L. Baechtold, Fitzpatrick, Celia, Harper &amp; Scinto, of New York, NY; and Edward W. Murray and Mary J. Morry, Merck &amp; Co., Inc., of Rahway, NJ.</attorneys>\n<p data-order=\"9\" data-type=\"judges\" id=\"A0k\">Before NEWMAN and MOORE, Circuit Judges, and FARNAN, District Judge.<footnotemark>**</footnotemark> MOORE, Circuit Judge.</p>\n<footnote data-order=\"10\" data-type=\"footnote\" id=\"x999-1\" label=\"*\">\n<p id=\"b890-19\"> Chief Judge Michel and Circuit Judge Schall did not participate in the vote.</p>\n</footnote>\n<footnote data-order=\"11\" data-type=\"footnote\" id=\"x999-2\" label=\"**\">\n<p id=\"b891-14\"> Hon. Joseph J. Faman, Jr., United States District Court for the District of Delaware, sitting by designation.</p>\n</footnote>\n<opinion data-order=\"12\" data-type=\"opinion\" id=\"x999-3\" type=\"majority\">\n<author id=\"b891-18\">MOORE, Circuit Judge.</author>\n<p id=\"b891-19\">In light of our decision in <em>In re Bilski, </em>545 F.3d 943 (Fed.Cir.2008) (en banc), we affirm the district court\u2019s grant of summary judgment that these claims are invalid under 35 U.S.C. \u00a7 101. Dr. Classen\u2019s claims are neither \u201ctied to a particular machine or apparatus\u201d nor do they \u201ctransforme ] a particular article into a different state or thing.\u201d <em>Bilski, </em>545 F.3d at 954. Therefore we <em>affirm.</em></p>\n</opinion>\n</casebody>\n",
    "status": "ok"
  }
}